MOONLAKE IMMUNOTHERAPEUTICS (MLTX)

KY61559X1045 - Common Stock

48.17  -2.04 (-4.06%)

After market: 48.17 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
N/AN/AN/AN/AN/A
348.55%
N/A
108.73%
N/A
65.38%
N/A
-6.66%
EBITDA
YoY % growth
N/AN/A-53.58M-65.05M
-21.41%
-54.11M
16.82%
N/A
-146.85%
N/A
-50.44%
N/A
-25.72%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
-105.76K-53.58M
-50,561.88%
-65.06M
-21.43%
-54.123M
16.81%
N/A
-159.67%
N/A
-45.65%
N/A
-31.03%
N/A
10.49%
N/A
136.41%
N/A
552.82%
N/A
116.95%
N/A
-15.35%
Operating Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/AN/AN/A-0.76
49.48%
N/A
-138.26%
N/A
-50.64%
N/A
-21.86%
N/A
-5.35%
N/A
96.70%
N/A
3,524.54%
N/A
118.73%
N/A
-0.08%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.63
-421.36%
-0.60
-174.70%
-0.65
-67.42%
-0.70
-25.02%
-0.68
-8.12%
-0.18
69.96%
-0.18
71.88%
-0.18
73.63%
-0.19
72.40%
Revenue
Q2Q % growth
N/AN/AN/AN/A
EBITDA
Q2Q % growth
-39.303M
-161.74%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-46.388M
-208.66%
-48.39M
-144.14%
-50.778M
-66.06%
-55.312M
-28.30%
-55.878M
-20.46%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.56
-211.11%
-0.44-0.12-26.10%
Q2 2024
Q2Q % growth
-0.39
-69.57%
-0.28-0.11-37.92%
Q1 2024
Q2Q % growth
-0.22
4.35%
-0.20-0.02-11.55%
Q4 2023
Q2Q % growth
-0.12
61.29%
-0.230.1148.88%
Q3 2023
Q2Q % growth
-0.18
33.33%
-0.230.0522.46%
Q2 2023
Q2Q % growth
-0.23
32.35%
-0.270.0415.13%
Q1 2023
Q2Q % growth
-0.23 -0.320.0927.32%
Q4 2022
Q2Q % growth
-0.31 -0.330.027.18%
Q3 2022
Q2Q % growth
-0.27 -0.330.0617.45%
Q2 2022
Q2Q % growth
-0.34 -0.550.2138.27%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -46.97% 0% -13.56%
RevenueN/A N/A N/A N/A